Certain antirheumatic drugs reduce risk of diabetes, study says

06/21/2011 | HealthDay News

Patients with rheumatoid arthritis or psoriasis who took tumor necrosis factor inhibitors were 38% less likely to develop type 2 diabetes over 12 years, while those who took methotrexate and hydroxychloroquine were 23% and 46% less likely, respectively, to develop the disease compared with those who took other disease-modifying antirheumatic drugs, according to a study in the Journal of the American Medical Association. The researcher noted that the study was observational and did not demonstrate causality.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR